CMS-2W2-27-001: Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Center for Medicare and Medicaid Services notices from 2026.
Center for Medicare and Medicaid Services offered grants of up to $3.3 million to any type of organization. It expected to make about 15 awards worth $100 million in total. Applications closed on May 15, 2026.
From the official notice on Grants.gov, last changed March 18, 2026. Checked November 7, 2026.
- Award ceiling$3.3 million
- Total funding$100 million
- Expected awards15
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 13, 2026 |
|---|---|
| Deadline | May 15, 2026 |
| Archived by Grants.gov | June 14, 2026 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Eligible applicants include any organization that meets the requirements outlined in this NOFO. Individuals are not eligible to apply. Examples of eligible applicants may include, but are not limited to: • Private medical practices. • Health systems and Accountable Care Organizations (ACOs). • Academic organizations. • Functional, lifestyle, preventive, and integrative medicine centers. • Community-based organizations (CBOs). • Federally Qualified Health Centers (FQHCs). • Rural Health Clinics (RHCs). • Indian Health Service/Tribal Services/Urban Indian Programs (ITUs). • Local and state governments. Organizations spanning multiple states are eligible to apply.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Centers for Medicare & Medicaid Services (CMS), through its Centers for Medicare and Medicaid Innovation (CMMI or Innovation Center), is soliciting applications for the Make America Healthy Again: Enhancing Lifestyle & Evaluating Value-based Approaches Through Evidence (MAHA ELEVATE) Model. This voluntary, three-year service delivery model is designed to test evidence-based, whole-person functional or lifestyle medicine (“whole-person FLM”) approaches to care. Rather than treating diseases separately after they develop, MAHA ELEVATE takes a proactive, comprehensive approach that combines psychological, nutritional, and physical interventions with personalized, lifestyle-based strategies for prevention and early treatment. Throughout this NOFO, we use the term “whole-person FLM” to represent a range of services or approaches often incorporated in lifestyle and functional medicine that are not currently covered under Medicare. It is important to clarify that CMS is not establishing a new industry standard through the use of this terminology. The term “whole-person FLM” as used in this NOFO does not represent an attempt by CMS to create, define, or establish any new industry-wide standard, practice guideline(s), or healthcare delivery model beyond the scope of this specific Innovation Center model and funding opportunity. Similarly, through this funding opportunity, CMS is not creating a new category of covered services for Medicare purposes. This term serves solely as a descriptive reference within this document to facilitate clear communication about the non-covered services being tested in this model and should not be interpreted as having any regulatory, coverage, or policy implications beyond the context of this specific Innovation Center model. CMS will select a total of up to 30 Recipients to participate in MAHA ELEVATE. The model will be split into two cohorts, one year apart (years 2026 and 2027). CMS will select recipients based on five key criteria: • Whole-person FLM intervention design, including cost savings. • Beneficiary recruitment and study design. • Organizational and administrative capacity. • Data management capabilities. • Budget. Highly competitive applicants must demonstrate several important strengths: • Strong, evidence-based support for your proposed intervention(s) and proof of your own successful history of implementation of the intervention and cost savings.
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CMS-2W2-27-001 still open?
No. It closed on May 15, 2026.
Who can apply for Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence?
Center for Medicare and Medicaid Services accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence?
Closed May 15, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $3.3 million each. About $100 million in total across about 15 awards.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)